Prospective Phase II Trial of [

Humans Positron Emission Tomography Computed Tomography / methods Gallium Radioisotopes Integrin alphaVbeta3 / metabolism Endothelial Cells / metabolism Prospective Studies Oligopeptides Neuroendocrine Tumors / diagnostic imaging Liver Neoplasms
PET integrin αvβ3 molecular imaging neuroendocrine neoplasms prognosis

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
02 2023
Historique:
received: 20 05 2022
revised: 13 08 2022
pubmed: 19 8 2022
medline: 4 2 2023
entrez: 18 8 2022
Statut: ppublish

Résumé

Integrin α

Identifiants

DOI: 10.2967/jnumed.122.264383 PMID: 35981899 PMC: PMC9902862
pubmed: 35981899
pii: jnumed.122.264383
doi: 10.2967/jnumed.122.264383
pmc: PMC9902862
doi:

Substances chimiques

1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane 0
Gallium Radioisotopes 0
Integrin alphaVbeta3 0
Oligopeptides 0

Types de publication

Clinical Trial, Phase II Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

252-259

Informations de copyright

© 2023 by the Society of Nuclear Medicine and Molecular Imaging.

Références

Nucl Med Biol. 2014 Mar;41(3):259-67
pubmed: 24417983
J Nucl Med. 2013 Oct;54(10):1755-9
pubmed: 23929824
J Nucl Med. 2021 Nov;62(11):1564-1570
pubmed: 33637589
Cancers (Basel). 2021 Oct 08;13(19):
pubmed: 34638512
EJNMMI Res. 2021 Aug 14;11(1):71
pubmed: 34390409
Neuroendocrinology. 2017 Feb 17;105(3):310-319
pubmed: 28222443
Cancers (Basel). 2021 Apr 04;13(7):
pubmed: 33916607
J Nucl Med. 2018 Dec;59(12):1809-1816
pubmed: 29700127
Cancer. 2012 Nov 15;118(22):5601-7
pubmed: 22517399
EJNMMI Res. 2020 May 7;10(1):47
pubmed: 32382869
Oncol Rep. 2009 Mar;21(3):769-75
pubmed: 19212638
Cancers (Basel). 2017 Sep 04;9(9):
pubmed: 28869579
JAMA Oncol. 2017 Oct 01;3(10):1335-1342
pubmed: 28448665
Acta Oncol. 2021 Jul;60(7):931-941
pubmed: 33999752
Front Oncol. 2018 Feb 12;8:24
pubmed: 29484286
Theranostics. 2019 Oct 16;9(25):7948-7960
pubmed: 31695808
EJNMMI Res. 2021 Oct 12;11(1):106
pubmed: 34636990
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
J Nucl Med. 2020 Feb;61(2):222-227
pubmed: 32015164
J Clin Oncol. 2008 Dec 1;26(34):5610-7
pubmed: 18981465
Diagnostics (Basel). 2022 Mar 30;12(4):
pubmed: 35453899
J Nucl Med. 2021 Jun 1;62(6):808-815
pubmed: 33067340
Front Oncol. 2021 Aug 11;11:706141
pubmed: 34458147
ACS Pharmacol Transl Sci. 2019 Aug 02;2(6):387-401
pubmed: 32259072
Gastric Cancer. 2015 Oct;18(4):784-95
pubmed: 25315085
Virchows Arch. 2014 Jan;464(1):69-78
pubmed: 24276405
Clin Nucl Med. 2019 Sep;44(9):687-694
pubmed: 31274560
PLoS One. 2012;7(12):e51862
pubmed: 23251644
Ann Rheum Dis. 2014 Jun;73(6):1269-72
pubmed: 24532680
Neuroendocrinology. 2019;109(2):83-99
pubmed: 30699437
Molecules. 2021 Mar 22;26(6):
pubmed: 33810198
Lancet Oncol. 2014 Sep;15(10):1100-8
pubmed: 25163906

Auteurs

Esben Andreas Carlsen (EA)

Department of Clinical Physiology and Nuclear Medicine & Cluster for Molecular Imaging, Copenhagen University Hospital, Rigshospitalet & Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
ENETS Neuroendocrine Tumor Center of Excellence, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Mathias Loft (M)

Department of Clinical Physiology and Nuclear Medicine & Cluster for Molecular Imaging, Copenhagen University Hospital, Rigshospitalet & Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
ENETS Neuroendocrine Tumor Center of Excellence, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Annika Loft (A)

Department of Clinical Physiology and Nuclear Medicine & Cluster for Molecular Imaging, Copenhagen University Hospital, Rigshospitalet & Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
ENETS Neuroendocrine Tumor Center of Excellence, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Dorota Czyzewska (D)

Department of Clinical Physiology and Nuclear Medicine & Cluster for Molecular Imaging, Copenhagen University Hospital, Rigshospitalet & Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
ENETS Neuroendocrine Tumor Center of Excellence, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Mikkel Andreassen (M)

ENETS Neuroendocrine Tumor Center of Excellence, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Department of Clinical Endocrinology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Seppo W Langer (SW)

ENETS Neuroendocrine Tumor Center of Excellence, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Department Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; and.

Ulrich Knigge (U)

ENETS Neuroendocrine Tumor Center of Excellence, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Department of Clinical Endocrinology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Department of Surgical Gastroenterology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Andreas Kjaer (A)

Department of Clinical Physiology and Nuclear Medicine & Cluster for Molecular Imaging, Copenhagen University Hospital, Rigshospitalet & Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark; akjaer@sund.ku.dk.
ENETS Neuroendocrine Tumor Center of Excellence, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Prospective Phase II Trial of [
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission de positons › Tomographie par émission de positons couplée à la tomodensitométrie › Prospective Phase II Trial of [
questionsmedicales.fr › Produits chimiques inorganiques › Métaux › Métaux lourds › Gallium › Isotopes du gallium › Radio-isotopes du gallium › Prospective Phase II Trial of [
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs immunologiques › Glycoprotéines de membrane plaquettaire › Intégrine alphaVbêta3 › Prospective Phase II Trial of [
questionsmedicales.fr › Cellules › Cellules épithéliales › Cellules endothéliales › Prospective Phase II Trial of [
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études prospectives › Prospective Phase II Trial of [
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Oligopeptides › Prospective Phase II Trial of [
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs du tissu nerveux › Tumeurs neuroectodermiques › Tumeurs neuroendocrines › Prospective Phase II Trial of [
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies du foie › Tumeurs du foie › Prospective Phase II Trial of [